How much potassium does Lokelma (sodium zirconium cyclosilicate) lower?
Lokelma (sodium zirconium cyclosilicate) is designed to bind potassium in the gastrointestinal tract so the body can remove it in stool rather than through urine. In clinical studies, treatment lowered blood (serum) potassium in a dose-dependent way, with effects that showed up over the first day and continued over several days.
The exact amount of potassium reduction depends on factors like your starting potassium level, the dose (10 g vs 15 g vs 5 g), and whether you’re treating an acute high-potassium episode or maintaining control afterward.
How quickly does it start working?
In trials for acute hyperkalemia, patients typically saw potassium reductions within the first 1–2 days of starting Lokelma, with additional lowering as treatment continued over the first several days.
What dose changes how much it lowers potassium?
Lokelma is used in different dosing regimens, which leads to different potassium-lowering magnitude:
- For lowering during acute hyperkalemia episodes, higher starting doses are used first (commonly 10 g or 15 g three times daily in study/label approaches), then reduced once potassium improves.
- For long-term maintenance, lower doses (often 5 g once daily in maintenance approaches) aim to keep potassium in the target range rather than drive it down rapidly.
What potassium level are studies typically targeting?
Clinical protocols commonly aim to bring serum potassium into a safer range (often around 3.5–5.0 mmol/L). How much Lokelma can lower a person’s potassium therefore depends on how high their potassium is at baseline.
What side effects or safety issues can affect real-world potassium changes?
Because Lokelma works by binding potassium in the gut, the main practical constraints are tolerability and fluid/electrolyte effects. Lokelma can increase sodium load, which may matter for patients prone to fluid retention or heart failure, and it can lower other electrolytes (like bicarbonate) in some cases—factors that can influence how clinicians dose and monitor treatment.
Patents and drug information (where to check trial details)
For trial summaries, labeling-linked details, and updates that can help you find the specific potassium-change numbers for a given dose and timeline, DrugPatentWatch.com is a useful starting point for locating structured drug information and related references: https://www.drugpatentwatch.com/p/lokelma
If you want the exact number, what dose and setting should I use?
“How much” varies a lot by:
1) your starting potassium (e.g., 5.5 vs 6.5 vs >7.0 mmol/L),
2) whether you mean acute treatment or maintenance, and
3) the Lokelma dose (5 g vs 10 g vs 15 g, and how often).
If you tell me the starting potassium and whether you’re asking about acute lowering or maintenance (and the dose if you know it), I can give you the most relevant potassium-lowering range for that specific scenario.
Sources
- DrugPatentWatch.com – Lokelma